Cargando…
Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease
Early identification of cognitive impairment in Parkinson’s disease (PD) has important clinical and research implications. The aim of our study was to investigate the role of plasma tau phosphorylated at amino acid 181 (p-tau181) and plasma neurofilament light chain (NfL) as biomarkers of cognition...
Autores principales: | Batzu, Lucia, Rota, Silvia, Hye, Abdul, Heslegrave, Amanda, Trivedi, Dhaval, Gibson, Lucy L., Farrell, Chloe, Zinzalias, Pavlos, Rizos, Alexandra, Zetterberg, Henrik, Chaudhuri, K. Ray, Aarsland, Dag |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653432/ https://www.ncbi.nlm.nih.gov/pubmed/36371469 http://dx.doi.org/10.1038/s41531-022-00384-x |
Ejemplares similares
-
Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease
por: Moscoso, Alexis, et al.
Publicado: (2021) -
Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression
por: Clark, Christopher, et al.
Publicado: (2021) -
Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression
por: Thompson, Andrew Geoffrey Bourne, et al.
Publicado: (2018) -
Serum phosphorylated tau protein 181 and neurofilament light chain in cognitively impaired heart failure patients
por: Traub, Jan, et al.
Publicado: (2022) -
Plasma phosphorylated tau181 and neurodegeneration in Alzheimer’s disease
por: Hansson, Oskar, et al.
Publicado: (2020)